1-3 of 3
Su-Jun Gao
Close
Sort by
Journal Articles

Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study

Clinical Trials & Observations
Li-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, Ming-Zhi Zhang, Zhi-Ming Li, Chun-Yan Ji, Wei Xu, Ting Liu, Bing Xu, Xin Wang, Su-Jun Gao, Hui-Lai Zhang, Yu Hu, Yan Li, Ying Cheng, Hai-Yan Yang, Jun-Ning Cao, Zun-Min Zhu, Jian-Da Hu, Wei Zhang, Hong-Mei Jing, Kai-Yang Ding, Xiang-Yang Zhang, Ren-Bin Zhao, Bin Zhang, Ya-Min Tian, Yong-Ping Song, Yu-Qin Song, Jun Zhu
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4349–4357.
https://doi.org/10.1182/bloodadvances.2022009168
Published: 2023
Includes: Supplemental data
Journal Articles

A global study for acute myeloid leukemia with RARG rearrangement

Hong-Hu Zhu, Ya-Zhen Qin, Zhang-Lin Zhang, Yong-Jing Liu, Li-Jun Wen, M. James You, Cheng Zhang, Esperanza Such, Hong Luo, Hong-Jian Yuan, Hong-Sheng Zhou, Hong-Xing Liu, Reng Xu, Ji Li, Jian-Hu Li, Jian-Ping Hao, Jie Jin, Liang Yu, Jing-Ying Zhang, Li-Ping Liu, Le-Ping Zhang, Rui-Bin Huang, Shu-Hong Shen, Su-Jun Gao, Wei Wang, Xiao-Jing Yan, Xin-You Zhang, Xin Du, Xiao-Xia Chu, Yan-Fang Yu, Yi Wang, Ying-Chang Mi, Ying Lu, Zhen Cai, Zhan Su, David Christopher Taussig, Suzanne MacMahon, Edward D. Ball, Huan-You Wang, John S. Welch, C. Cameron Yin, Gautam Borthakur, Miguel A. Sanz, Hagop M. Kantarjian, Jin-Yan Huang, Jiong Hu, Su-Ning Chen
Journal: Blood Advances
Blood Adv (2023) 7 (13): 2972–2982.
https://doi.org/10.1182/bloodadvances.2022008364
Published: 2023
Includes: Supplemental data
Journal Articles

Overexpression of WT1 and PRAME predicts poor outcomes of patients with myelodysplastic syndromes with thrombocytopenia

Clinical Trials & Observations
Qiu-Sha Huang, Jing-Zhi Wang, Ya-Zhen Qin, Qiao-Zhu Zeng, Qian Jiang, Hao Jiang, Jin Lu, Hui-Xin Liu, Yi Liu, Jing-Bo Wang, Li Su, Hong-Yu Zhang, Zhen-Ling Li, Su-Jun Gao, Bo Huang, Yu-Ying Liu, Yan-Rong Liu, Lan-Ping Xu, Xiao-Jun Huang, Xiao-Hui Zhang
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3406–3418.
https://doi.org/10.1182/bloodadvances.2019000564
Published: 2019
Includes: Supplemental data